1. Home
  2. JD vs IQV Comparison

JD vs IQV Comparison

Compare JD & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JD.com Inc.

JD

JD.com Inc.

HOLD

Current Price

$29.50

Market Cap

42.3B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$225.11

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JD
IQV
Founded
2006
1982
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.3B
36.4B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
JD
IQV
Price
$29.50
$225.11
Analyst Decision
Buy
Buy
Analyst Count
11
17
Target Price
$42.00
$237.59
AVG Volume (30 Days)
11.7M
1.4M
Earning Date
11-13-2025
10-28-2025
Dividend Yield
3.38%
N/A
EPS Growth
N/A
N/A
EPS
2.99
7.30
Revenue
$183,136,729,092.00
$15,904,000,000.00
Revenue This Year
$15.80
$6.14
Revenue Next Year
$5.55
$5.35
P/E Ratio
$9.89
$30.94
Revenue Growth
16.63
3.85
52 Week Low
$28.21
$134.65
52 Week High
$46.45
$234.30

Technical Indicators

Market Signals
Indicator
JD
IQV
Relative Strength Index (RSI) 40.49 55.28
Support Level $29.11 $217.86
Resistance Level $29.90 $230.80
Average True Range (ATR) 0.43 5.52
MACD 0.15 -1.08
Stochastic Oscillator 68.38 53.14

Price Performance

Historical Comparison
JD
IQV

About JD JD.com Inc.

JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2024. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: